Related references
Note: Only part of the references are listed.Aliskiren and the calcium channel blocker amlodipine combination as an initial treatment strategy for hypertension control (ACCELERATE): a randomised, parallel-group trial
Morris J. Brown et al.
LANCET (2011)
Renin Inhibitors in Chronic Heart Failure: The Aliskiren Observation of Heart Failure Treatment Study in Context
Henry Krum et al.
CLINICAL CARDIOLOGY (2010)
Impact of Baseline Renal Function on the Efficacy and Safety of Aliskiren Added to Losartan in Patients With Type 2 Diabetes and Nephropathy
Frederik Persson et al.
DIABETES CARE (2010)
Aliskiren A Review of its Use as Monotherapy and as Combination Therapy in the Management of Hypertension
Sean T. Duggan et al.
DRUGS (2010)
Patients with acute coronary syndromes and elevated levels of natriuretic peptides: the results of the AVANT GARDE-TIMI 43 Trial
Benjamin M. Scirica et al.
EUROPEAN HEART JOURNAL (2010)
Aliskiren Alone or in Combination With Hydrochlorothiazide in Patients With the Lower Ranges of Stage 2 Hypertension: The ACQUIRE Randomized Double-Blind Study
Henry R. Black et al.
JOURNAL OF CLINICAL HYPERTENSION (2010)
Effect of the Direct Renin Inhibitor Aliskiren, the Angiotensin Receptor Blocker Losartan, or Both on Left Ventricular Mass in Patients With Hypertension and Left Ventricular Hypertrophy
Scott D. Solomon et al.
CIRCULATION (2009)
A study of the pharmacokinetic interactions of the direct renin inhibitor aliskiren with allopurinol, celecoxib and cimetidine in healthy subjects
Surya Ayalasomayajula et al.
CURRENT MEDICAL RESEARCH AND OPINION (2008)
Renin Inhibition Attenuates Insulin Resistance, Oxidative Stress, and Pancreatic Remodeling in the Transgenic Ren2 Rat
Javad Habibi et al.
ENDOCRINOLOGY (2008)
Renin inhibitor aliskiren improves impaired nitric oxide Bioavailability and protects against atherosclerotic changes
Toshio Imanishi et al.
HYPERTENSION (2008)
Pharmacokinetics of the Oral Direct Renin Inhibitor Aliskiren in Combination With Digoxin, Atorvastatin, and Ketoconazole in Healthy Subjects: The Role of P-Glycoprotein in the Disposition of Aliskiren
Sujata Vaidyanathan et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Effects of the direct renin inhibitor aliskiren and atenolol alone or in combination in patients with hypertension
Rainer Dietz et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2008)
Aliskiren combined with losartan in type 2 diabetes and nephropathy
Hans-Henrik Parving et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
A comparison of the tolerability of the direct renin inhibitor aliskiren and lisinopril in patients with severe hypertension
R. H. Strasser et al.
JOURNAL OF HUMAN HYPERTENSION (2007)
Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomised, double-blind trial
Suzanne Oparil et al.
LANCET (2007)
Antihypertensive efficacy, safety, and tolerability of the oral direct renin inhibitor aliskiren in patients with hypertension: a pooled analysis
Matthew R. Weir et al.
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION (2007)
Direct renin inhibition with aliskiren in obese patients with arterial hypertension
Jens Jordan et al.
HYPERTENSION (2007)
Pharmacokinetics, safety, and tolerability of the novel oral direct renin inhibitor aliskiren in elderly healthy subjects
Sujata Vaidyanathan et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Aliskiren, an oral renin inhibitor, provides dose-dependent efficacy and sustained 24-hour blood pressure control in patients with hypertension
Byung-Hee Oh et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Aliskiren for renin inhibition: A new class of antihypertensives
Benjamin W. Van Tassell et al.
ANNALS OF PHARMACOTHERAPY (2007)
Pharmacokinetics, safety, and tolerability of the oral renin inhibitor aliskiren in patients with hepatic impairment
Sujato Vaidyanathan et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker
Eoin O'Brien et al.
HYPERTENSION (2007)
Renin inhibition with aliskiren provides additive anti hypertensive efficacy when used in combination with hydrochlorothiazide
Alberto Villamil et al.
JOURNAL OF HYPERTENSION (2007)
Pharmacokinetics of the oral direct renin inhibitor aliskiren alone and in combination with irbesartan in renal impairment
Sujata Vaidyanathan et al.
CLINICAL PHARMACOKINETICS (2007)
Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan
James L. Pool et al.
AMERICAN JOURNAL OF HYPERTENSION (2007)
Aliskiren, a novel orally effective renin inhibitor, exhibits similar pharmacokinetics and pharmacodynamics in Japanese and Caucasian subjects
Sujata Vaidyanathan et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Aliskiren, a novel oral renin inhibitor, provides dose-dependent efficacy and placebo-like tolerability in Japanese patients with hypertension
Toshio Kushiro et al.
HYPERTENSION RESEARCH (2006)
Renin, prorenin and the putative (pro)renin receptor
AHJ Danser et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2005)
Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients
AH Gradman et al.
CIRCULATION (2005)
Structure-based design of aliskiren, a novel orally effective renin inhibitor
JM Wood et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Blood pressure lowering in essential hypertension with an oral renin inhibitor, aliskiren
A Stanton et al.
HYPERTENSION (2003)
Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100) - Comparison with enalapril
J Nussberger et al.
HYPERTENSION (2002)
Plasma prorenin levels may predict persistent microalbuminuria in children with diabetes
F Chiarelli et al.
PEDIATRIC NEPHROLOGY (2001)
Angiotensin II receptor antagonists
M Burnier et al.
LANCET (2000)
Share Paper
